Patient Guide: A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 180 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06868277
Status: 🟢 Enrolling Now
Condition: Carcinoma, Non-Small Cell Lung
Phase: PHASE3

Where You Can Participate

This study is available at 180 locations across the country.

Top locations include:
  • • Bay Pines, Florida
  • • Clearwater, Florida
  • • Saint Petersburg, Florida
  • • And 177 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer - Join Clinical Trial NCTNCT06868277

How to Join This Clinical Trial - NCTNCT06868277

Learn how to participate in this PHASE3 trial studying an investigational therapy for Carcinoma, Non-Small Cell Lung. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Carcinoma, Non-Small Cell Lung. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Carcinoma, Non-Small Cell Lung
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06868277 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 180 locations. Find a study site near you:

Clinical Research Site

Bay Pines, Florida 33744 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Clearwater, Florida 33756 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Saint Petersburg, Florida 33705 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Marietta, Georgia 30060 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Decatur, Illinois 62526 - United States

Status: RECRUITING

Clinical Research Site

Des Moines, Iowa 50309 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Leawood, Kansas 66209 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Lexington, Kentucky 40536 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Frederick, Maryland 21702 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Silver Spring, Maryland 20910 - United States

Status: NOT_YET_RECRUITING

And 170 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Carcinoma, Non-Small Cell Lung:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships